Literature DB >> 30040864

Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Hiroyuki Motoyama, Akihiro Tamori, Shoji Kubo, Sawako Uchida-Kobayashi, Shigekazu Takemura, Shogo Tanaka, Satoko Ohfuji, Yuga Teranishi, Ritsuzo Kozuka, Etsushi Kawamura, Atsushi Hagihara, Hiroyasu Morikawa, Masaru Enomoto, Yoshiki Murakami, Norifumi Kawada.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0194163.].

Entities:  

Year:  2018        PMID： 30040864      PMCID： PMC6057673          DOI： 10.1371/journal.pone.0201423

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


In the Funding section, a second grant number from the Japan Society for the Promotion of Science is missing. The correct funding information is as follows: This study was supported in part by the Japan Society for the Promotion of Science grant (JSPS KAKENHI Grant No. JP15K09019, A.T., and JP17H04124, S.O.). Web site; http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Authors:  Hiroyuki Motoyama; Akihiro Tamori; Shoji Kubo; Sawako Uchida-Kobayashi; Shigekazu Takemura; Shogo Tanaka; Satoko Ohfuji; Yuga Teranishi; Ritsuzo Kozuka; Etsushi Kawamura; Atsushi Hagihara; Hiroyasu Morikawa; Masaru Enomoto; Yoshiki Murakami; Norifumi Kawada
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.